An autochthonous case of severe plasmodium knowlesi malaria in Thailand

American Journal of Tropical Medicine and Hygiene

Volumn 92, Issue 3, 2015, Pages 569-572

  Nakaviroj, Surat ^a   Kobasa, Teerayot ^b   Teeranaipong, Phairote ^c   Putaporntip, Chaturong ^c   Jongwutiwes, Somchai ^c  

^a PRAPOKKLAO HOSPITAL   (Thailand)

^b MINISTRY OF PUBLIC HEALTH   (Thailand)

^c CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; AMINOTRANSFERASE; ARTESUNATE; ASPARTIC ACID; BILIRUBIN GLUCURONIDE; DOPAMINE; INFUSION FLUID; RNA 18S; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE;

ADULT; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD CELL COUNT; BLOOD SMEAR; CAMPING; CASE REPORT; CHILL; CLINICAL FEATURE; DISEASE DURATION; EYE JAUNDICE; FEVER; FOLLOW UP; HEAT EXHAUSTION; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; KIDNEY FAILURE; LETHARGY; LIVER FUNCTION TEST; LOSS OF APPETITE; MALAISE; MALE; MIDDLE AGED; MYALGIA; OLIGURIA; PALLOR; PLASMODIUM KNOWLESI MALARIA; POLYMERASE CHAIN REACTION; REVIEW; SCHIZONT; SCLERA; THAILAND; THROMBOCYTOPENIA; TREATMENT DURATION; TROPHOZOITE; ISOLATION AND PURIFICATION; MALARIA; PARASITOLOGY; PLASMODIUM KNOWLESI;

PLASMODIUM KNOWLESI; SIMIAE;

ANTIMALARIALS; ARTEMISININS; HUMANS; MALARIA; MALE; MIDDLE AGED; PLASMODIUM KNOWLESI; THAILAND;

EID: 84924265109     PISSN: 00029637     EISSN: 14761645     Source Type: Journal    
DOI: 10.4269/ajtmh.14-0610     Document Type: Review

References (21)

1. Coatney GR, Collins WE, Warren M, Contacos PG, 2003. The Primate Malarias. [original book published 1971] [CDROM]. Version 1.0. Atlanta, GA: Centers for Disease Control and Prevention.
2. Daneshvar C, Davis TM, Cox-Singh J, Rafa'ee MZ, Zakaria SK, Divis PC, Singh B, 2009. Clinical and laboratory features of human Plasmodium knowlesi infection. Clin Infect Dis 49: 852-860.
3. William T, Menon J, Rajahram G, Chan L, Ma G, Donaldson S, Khoo S, Frederick C, Jelip J, Anstey NM, Yeo TW, 2011. Severe Plasmodium knowlesi malaria in a tertiary care hospital, Sabah Malaysia. Emerg Infect Dis 17: 1248-1255.
4. Putaporntip C, Hongsrimuang T, Seethamchai S, Kobasa T, Limkittikul K, Cui L, Jongwutiwes S, 2009. Differential prevalence of Plasmodium infections and cryptic Plasmodium knowlesi malaria in humans in Thailand. J Infect Dis 199: 1143-1150.
5. Jongwutiwes S, Buppan P, Kosuvin R, Seethamchai S, Pattanawong U, Sirichaisinthop J, Putaporntip C, 2011. Plasmodium knowlesi malaria in humans and macaques, Thailand. Emerg Infect Dis 17: 1799-1806.
6. Grigg MJ, William T, Dhanaraj P, Menon J, Barber BE, von Seidlein L, Rajahram G, Price RN, Anstey NM, Yeo TW, 2014. A study protocol for a randomized open-label clinical trial of artesunate-mefloquine versus chloroquine in patients with non-severe Plasmodium knowlesi malaria in Sabah, Malaysia (ACT KNOW trial). BMJ Open 4: e006005.
7. Sitprija V, Indraprasit S, Pochanugool C, Benyajati C, Piyaratn P, 1967. Renal failure in malaria. Lancet 7483: 185-188.
8. Sitprija V, Vongsthongsri M, Poshyachinda V, Arthachinta S, 1977. Renal failure in malaria: a pathophysiologic study. Nephron 18: 277-287.
9. Boonpucknavig V, Sitprija V, 1979. Renal disease in acute Plasmodium falciparum infection in man. Kidney Int 16: 44-52.
10. Hanson JP, Lam SW, Mohanty S, Alam S, Pattnaik R, Mahanta KC, Hasan MU, Charunwatthana P, Mishra SK, Day NP, White NJ, Dondorp AM, 2013. Fluid resuscitation of adults with severe falciparum malaria: effects on acid-base status, renal function, and extravascular lung water. Crit Care Med 41: 972-981.
11. Hanson J, Lam SW, Mahanta KC, Pattnaik R, Alam S, Mohanty S, Hasan MU, Hossain A, Charunwatthana P, Chotivanich K, Maude RJ, Kingston H, Day NP, Mishra S, White NJ, Dondorp AM, 2012. Relative contributions of macrovascular and microvascular dysfunction to disease severity in falciparum malaria. J Infect Dis 206: 571-579.
12. Perkins DJ, Were T, Davenport GC, Kempaiah P, Hittner JB, Ong'echa JM, 2011. Severe malarial anemia: innate immunity and pathogenesis. Int J Biol Sci 7: 1427-1442.
13. World Health Organization, 1990. Severe and complicated malaria. Trans R Soc Trop Med Hyg 84 (Suppl 2): 1-65.
14. Sadun EH, Williams JS, Martin LK, 1966. Serum biochemical changes in malarial infections in men, chimpanzees and mice. Mil Med 131 (Suppl): 1094-1106.
15. Lacerda MV, Mouraõ MP, Coelho HC, Santos JB, 2011. Thrombocytopenia in malaria: who cares? Mem Inst Oswaldo Cruz 106 (Suppl 1): 52-63.
16. Muniz-Junqueira MI, dos Santos-Neto LL, Tosta CE, 2001. Influence of tumor necrosis factor-alpha on the ability of monocytes and lymphocytes to destroy intraerythrocytic Plasmodium falciparum in vitro. Cell Immunol 208: 73-79.
17. Mohan K, Dubey ML, Ganguly NK, Mahajan RC, 1995. Plasmodium falciparum: role of activated blood monocytes in erythrocyte membrane damage and red cell loss during malaria. Exp Parasitol 80: 54-63.
18. Barber BE, William T, Grigg MJ, Menon J, Auburn S, Marfurt J, Anstey NM, Yeo TW, 2013. A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy. Clin Infect Dis 56: 383-397.
19. Fatih FA, Staines HM, Siner A, Ahmed MA, Woon LC, Pasini EM, Kocken CH, Singh B, Cox-Singh J, Krishna S, 2013. Susceptibility of human Plasmodium knowlesi infections to anti-malarials. Malar J 12: 425.
20. World Health Organization, 2014. Severe malaria. Trop Med Int Health 19 (Suppl 1): 7-131.
21. Orth H, Jensen BO, Holtfreter MC, Kocheril SJ, Mallach S, MacKenzie C, Müller-Stöver I, Henrich B, Imwong M, White NJ, Häussinger D, Richter J, 2013. Plasmodium knowlesi infection imported to Germany, January 2013. Euro Surveill 18: 20603.